“Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways”, JOC, vol. 5, no. 1, Feb. 2006, Accessed: Dec. 07, 2025. [Online]. Available: https://carcinogenesis.com/index.php/JOC/article/view/227